Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine Tumors

医学 内科学 神经内分泌肿瘤 胃肠病学 相伴的 比例危险模型 放射性核素治疗 化疗 转移 肿瘤科 奥曲肽 入射(几何) 回顾性队列研究 癌症 生长抑素 物理 光学
作者
Saneya Pandrowala,Deeksha Kapoor,Aditya Kunte,Amit Chopde,Ameya Puranik,Indraja Dev,Rahul V. Parghane,Sandip Basu,Anant Ramaswamy,Vikas Ostwal,Vikram Chaudhari,Manish S. Bhandare,Shailesh V. Shrikhande
出处
期刊:Journal of Gastrointestinal Cancer [Springer Science+Business Media]
标识
DOI:10.1007/s12029-024-01077-9
摘要

Abstract Introduction The incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NET) has steadily increased. These tumors are considered relatively indolent even when metastatic. What determines survival outcomes in such situations is understudied. Materials and Methods Retrospective analysis of a prospectively maintained NET clinic database, to include patients of metastatic grade 1 GEP-NET, from January 2018 to December 2021, to assess factors affecting progression-free survival (PFS). Results Of the 589 patients of GEP-NET treated during the study period, 100 were grade 1, with radiological evidence of distant metastasis. The median age was 50 years, with 67% being men. Of these, 15 patients were observed, while 85 patients received treatment in the form of surgery ( n = 32), peptide receptor radionuclide therapy ( n = 50), octreotide LAR ( n = 22), and/or chemotherapy ( n = 4), either as a single modality or multi-modality treatment. The median (PFS) was 54.5 months. The estimated 3-year PFS and 3-year overall survival rates were 72.3% (SE 0.048) and 93.4% (SE 0.026), respectively. On Cox regression, a high liver tumor burden was the only independent predictor of PFS (OR 3.443, p = 0.014). The 5-year OS of patients with concomitant extra-hepatic disease was significantly lower than that of patients with liver-limited disease (70.7% vs. 100%, p = 0.017). Conclusion A higher burden of liver disease is associated with shorter PFS in patients with metastatic grade I GEP-NETs. The OS is significantly lower in patients with associated extrahepatic involvement. These parameters may justify a more aggressive treatment approach in metastatic grade 1 GEP-NETs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
梁伟鑫完成签到,获得积分10
刚刚
1秒前
丘比特的应助被合适的铃铛采纳,获得10
1秒前
111关闭了111的文献求助
1秒前
852的应助被11采纳,获得10
1秒前
花花发布了新的文献求助10
1秒前
2秒前
2秒前
2秒前
dyx发布了新的文献求助10
2秒前
2秒前
高等数学C2完成签到,获得积分10
3秒前
3秒前
居居发布了新的文献求助10
3秒前
24307完成签到,获得积分10
3秒前
4秒前
4秒前
dazhu完成签到 ,获得积分10
4秒前
烟花的应助被嵇老五采纳,获得10
4秒前
情怀的应助被海慕云采纳,获得10
5秒前
Ttttt完成签到,获得积分20
5秒前
孤独的迎滑完成签到,获得积分10
5秒前
Jenny完成签到,获得积分10
5秒前
23202完成签到,获得积分10
5秒前
JamesPei的应助被xiaofu采纳,获得10
5秒前
你好发布了新的文献求助10
5秒前
秋风的应助被我想静静采纳,获得10
5秒前
5秒前
小小彤完成签到,获得积分10
5秒前
dlwlrma发布了新的文献求助10
5秒前
张亚妮发布了新的文献求助10
6秒前
乔垣结衣发布了新的文献求助10
6秒前
drizzle发布了新的文献求助10
6秒前
小杨发布了新的文献求助10
6秒前
悦Rsh完成签到,获得积分20
6秒前
31483完成签到,获得积分10
6秒前
小满完成签到,获得积分10
7秒前
7秒前
田昆完成签到,获得积分10
7秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168976
求助须知:如何正确求助?哪些是违规求助? 9561992
关于积分的说明 21764222
捐赠科研通 7760642
什么是DOI,文献DOI怎么找? 3430195
关于科研通互助平台的介绍 2554066
邀请新用户注册赠送积分活动 2474834